Sorin Group Announces Start of Patient Enrolment in ‘Perceval S’ Sutureless Aortic Valve Clinical Trial in Europe

Sorin Group announced today the enrolment of the first three patients in a clinical trial aimed at obtaining European market approval for its ‘Perceval S’ Sutureless Aortic Heart Valve.